First Time Loading...

Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793

Watchlist Manager
Luoxin Pharmaceuticals Group Stock Co Ltd Logo
Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
Watchlist
Price: 4.63 CNY 2.89% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Luoxin Pharmaceuticals Group Stock Co Ltd

There are no price targets for Luoxin Pharmaceuticals Group Stock Co Ltd.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Luoxin Pharmaceuticals Group Stock Co Ltd Competitors:
Price Targets
185750
Chong Kun Dang Pharmaceutical Corp
40% Upside
SUPRIYA
Supriya Lifescience Ltd
3% Upside
A
AETHER
Aether Industries Ltd
36% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
15% Upside
185750
Chong Kun Dang Pharmaceutical Corp
40% Upside
SUPRIYA
Supriya Lifescience Ltd
3% Upside
A
AETHER
Aether Industries Ltd
36% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
15% Upside
VENUSREM
Venus Remedies Ltd
24% Upside
L
503
Lansen Pharmaceutical Holdings Ltd
78% Downside
P
PLTH
Planet 13 Holdings Inc
181% Upside
AVDL
Avadel Pharmaceuticals PLC
25% Upside

Revenue
Forecast

Revenue Estimate
Luoxin Pharmaceuticals Group Stock Co Ltd

For the last 8 years the compound annual growth rate for Luoxin Pharmaceuticals Group Stock Co Ltd's revenue is 27%. The projected CAGR for the next 2 years is 46%.

27%
Past Growth
46%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Luoxin Pharmaceuticals Group Stock Co Ltd

Operating Income forecast
is not available for
Luoxin Pharmaceuticals Group Stock Co Ltd

Net Income
Forecast

Net Income Estimate
Luoxin Pharmaceuticals Group Stock Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Luoxin Pharmaceuticals Group Stock Co Ltd's stock price target?
Not Available

Luoxin Pharmaceuticals Group Stock Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Luoxin Pharmaceuticals Group Stock Co Ltd's Revenue forecast?
Projected CAGR
46%

For the last 8 years the compound annual growth rate for Luoxin Pharmaceuticals Group Stock Co Ltd's revenue is 27%. The projected CAGR for the next 2 years is 46%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.